Edgewell Personal Care (NYSE:EPC) Misses Q2 CY2026 Revenue Estimates

Edgewell Personal Care (NYSE: EPC) reported Q2 CY2026 revenue of $570.1 million, up 1.7% year on year but below Wall Street estimates. Non-GAAP EPS was $0.72, 17.6% above consensus. The company cited improving organic net sales and North America performance. Shares were flat at $28.57 after the report.

Original reporting
Published Aug 5, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 12:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Edgewell Personal Care (NYSE:EPC) Misses Q2 CY2026 Revenue Estimates — source image
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

Traders should weigh the revenue and gross margin miss against the EPS and adjusted EBITDA outperformance, plus the modest organic growth turnaround after a prolonged period of organic declines.

02

Market read

This is a mixed earnings-style update: revenue and gross margin missed, while EPS and adjusted EBITDA beat, and organic sales showed a small YoY rebound.

03

What to watch

The article notes organic sales declined on average over eight quarters and gross margin fell short, which could outweigh the EPS beat for longer-term demand and pricing assumptions.

Relevance 6/10Novelty 6/10Timing: post-Q2 results, immediately after reporting

Background

Edgewell is a personal care company with brands including Banana Boat, Schick, and Skintimate, and it reported Q2 CY2026 results versus Wall Street expectations.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell (EPC) reported Q2 CY2026 revenue of $570.1M, up 1.7% YoY, but below Wall Street estimates.

Expected impact

Likely choppy trading, with downside risk if investors focus on organic demand softness and gross margin weakness.

Evidence & confidence

The article provides directionally conflicting signals: EPS beat and EBITDA outperformance versus revenue miss and gross margin shortfall, plus organic sales only modestly positive after eight quarters of decline.

Market effects

Signals ongoing demand and margin pressure in consumer/personal care, even when earnings can be supported by cost control.

No specific regional read-through provided beyond management commentary on North America improvement.

No explicit global macro or international catalyst described.

Counterpoint

Investors may look past the revenue miss because organic sales turned positive YoY in the quarter and management cited progress toward fiscal 2026 targets.

Key entities

  • Edgewell Personal Care

    Reported Q2 CY2026 revenue and profitability results versus consensus, including organic sales and margin commentary.

  • Rod Little

    CEO who said Q3 results represent progress toward fiscal 2026 progression, with organic net sales returning to growth.

Related articles

$EPCMedAI 8/10

Edgewell Personal Care Q3 Earnings Call Highlights

Edgewell Personal Care (EPC) reported Q3 organic sales trends: wet shave organic sales fell 1.9% as private-label supply disruptions outweighed branded growth, while U.S. razors and blades consumption rose with higher promotions. Sun and skin care organic sales rose 5%. Adjusted operating income was $53M (9.3% margin); GAAP EPS $0.26 vs $0.46. Fiscal 2026 adjusted EPS guidance is $1.80-$2.00.

$EPCMed

Edgewell Personal Care Announces Third Quarter Fiscal 2026 Results

Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 third-quarter results ended June 30, 2026. Net sales rose 1.7% to $570.1M, with organic sales up 1.1%. Adjusted EPS was $0.72, flat year over year, while GAAP diluted EPS was $0.26. The company said full-year outlook was narrowed, with adjusted EPS and EBITDA midpoints unchanged, and declared a $0.15 dividend.

$EPCMed

EDGEWELL PERSONAL CARE Co (EPC): Results of Operations and Financial Condition

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q3fy26-epcexhibit991.htm EX-99.1 Document Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care A

$EPCMedAI 8/10

Why Is Edgewell Personal Care (EPC) Stock Soaring Today

Edgewell Personal Care (EPC) shares rose 13.7% in the afternoon after the company rejected an unsolicited takeover offer from private equity firm Yellow Wood Partners, priced at $30 per share, according to reports. The board reportedly viewed the bid as too low. The stock is up 55.6% year-to-date and trades near its 52-week high.

$MUMed

Stocks making the biggest moves midday: Micron Technology, SpaceX, IBM, Flex & more

Midday movers: Micron fell over 10% amid a broader tech selloff; Marvell slid 8% and Sandisk dropped 11%. Accenture rose nearly 2% after raising its buyback by $2B to over $7B. Flex fell over 2% after COO sold 36,000 shares. IBM gained over 4% after a JPMorgan overweight upgrade. Carnival dropped 6% on weaker Q3 guidance. AMC sank 25% on a planned 95.3M-share sale.

$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.